ASMB Earnings & Financial Statements
Assembly Biosciences, Inc.
$20.66
+$0.13(+0.63%)
32
Overall
40
Value
18
Tech
39
Quality
Market Cap
$418.00M
Volume
30.60K
52W Range
$21.80 - $39.71
Target Price
$49.67
ASMB earnings and financial statements: Assembly Biosciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ASMB Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $72.30M | $28.52M | $7.16M | $153.0K | $6.25M |
| Operating income | -$12.12M | -$45.42M | -$64.65M | -$94.11M | -$132.69M |
| EBITDA | -$6.11M | -$39.72M | -$64.20M | -$92.44M | -$90.58M |
| Net income | -$6.12M | -$40.18M | -$61.23M | -$93.09M | -$129.85M |
| EPS (diluted) | $-0.55 | $-6.69 | $-13.38 | $-23.04 | $-36.00 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $257.59M | $119.17M | $136.82M | $101.79M | $191.06M |
| Total liabilities | $50.84M | $85.81M | $95.73M | $19.13M | $22.13M |
| Shareholders’ equity | $206.75M | $33.36M | $41.10M | $82.66M | $168.93M |
| Cash and equivalents | $58.45M | $38.34M | $19.84M | $52.42M | $45.63M |
| Long-term debt | $2.06M | $2.63M | $1.12M | $101.0K | $3.33M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$41.09M | -$51.12M | $22.74M | -$84.46M | -$93.43M |
| Capital expenditure | -$66.0K | -$28.0K | -$255.0K | -$102.0K | -$3.10M |
| Free cash flow | -$41.16M | -$51.15M | $22.49M | -$84.56M | -$96.49M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASMB | $20.66 | +0.6% | 30.60K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Assembly Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW